These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8644849)

  • 1. Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers.
    Li ZH; Salovaara R; Aaltonen LA; Shibata D
    Am J Pathol; 1996 Apr; 148(4):1075-9. PubMed ID: 8644849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers.
    Cheng AJ; Tang R; Wang JY; See LC; Wang TC
    J Natl Cancer Inst; 1998 Feb; 90(4):316-21. PubMed ID: 9486818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers.
    Behrens P; Mathiak M; Mangold E; Kirdorf S; Wellmann A; Fogt F; Rothe M; Florin A; Wernert N
    Int J Cancer; 2003 Nov; 107(2):183-8. PubMed ID: 12949792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between microsatellite instability and telomere shortening in colorectal cancer.
    Takagi S; Kinouchi Y; Hiwatashi N; Nagashima F; Chida M; Takahashi S; Negoro K; Shimosegawa T; Toyota T
    Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S12-7. PubMed ID: 11052472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer.
    Yamamoto H; Sawai H; Weber TK; Rodriguez-Bigas MA; Perucho M
    Cancer Res; 1998 Mar; 58(5):997-1003. PubMed ID: 9500462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.
    Aaltonen LA; Peltomäki P; Mecklin JP; Järvinen H; Jass JR; Green JS; Lynch HT; Watson P; Tallqvist G; Juhola M
    Cancer Res; 1994 Apr; 54(7):1645-8. PubMed ID: 8137274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
    Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
    Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulators and apoptosis-associated proteins in relation to proliferative activity and degree of apoptosis in HNPCC versus sporadic endometrial carcinoma.
    Rijcken F; van der Zee A; van der Sluis T; Boersma-van Ek W; Kleibeuker J; Hollema H
    Histopathology; 2006 Feb; 48(3):275-85. PubMed ID: 16430474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
    Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
    Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumoral expression of nuclear cofactor FHL2 is associated with lymphatic metastasis in sporadic but not in HNPCC-associated colorectal cancer.
    Al-Nomani L; Friedrichs J; Schüle R; Büttner R; Friedrichs N
    Pathol Res Pract; 2015 Feb; 211(2):171-4. PubMed ID: 25554651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
    Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
    Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
    Katayama S; Shiota G; Kawasaki H
    Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activation in colorectal carcinogenesis.
    Yan P; Saraga EP; Bouzourene H; Bosman FT; Benhattar J
    J Pathol; 1999 Oct; 189(2):207-12. PubMed ID: 10547576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.
    Katayama S; Shiota G; Oshimura M; Kawasaki H
    J Cancer Res Clin Oncol; 1999 Jul; 125(7):405-10. PubMed ID: 10394961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.